Table 2.

Relative triacylglycerol content (arbitrary units) after quercetin treatment in maturing preadipocytes and mature adipocytes.

	C	Q0.1	P	Q0.5	P	Q1	P	Q2	P	Q5	P	Q10	P
Stage of adipogenesis
Whole adipogenesis (d0–d8)	100 ± 5.1	77.95 ± 12.8	0.09	75.57 ± 8.6	<0.01	58.4 ± 8.6	<0.001	81.3 ± 7.4	<0.05	79.6 ± 7.2	<0.05	62.9 ± 10.2	<0.01
Early stage (day 0–60 hours)	100 ± 6.9					86.0 ± 5.7	0.09					95.3 ± 7.3	ND
Late stage (60 hours–d8)						92.2 ± 5.6	ND					75.9 ± 10.5	<0.05
Mature adipocytes (d12 for 24 h)	100 ± 6.3					109.3 ± 34.0	ND	86.2 ± 3.4	0.07	79.3 ± 12.8	0.10	76.3 ± 4.8	<0.01

C = control; ND = no difference, Q0.1 = 0.1 µM of quercetin, Q0.5 = 0.5 µM of quercetin, Q1 = 1 µM of quercetin, Q2 = 2 µM of quercetin, Q5 = 5 µM of quercetin, and Q10 = 10 µM of quercetin.

Values are means ± SEM. Comparisons between each treatment and the controls were analyzed by Student's t-test. The difference was established at P ≤ 0.10.